We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01613391
First Posted: June 7, 2012
Last Update Posted: June 11, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Muhammet Ferhat CELİK, Istanbul University
June 5, 2012
June 7, 2012
June 11, 2012
July 2011
February 2012   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01613391 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides
Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides
This study aimed to measure, compare apelin, resistin, visfatin levels in patients underwent to RYGBP, LAGB and their relation with obesity.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Morbidly obese 15 patients underwent LAGB and 15 patients underwent RYGBP
Morbid Obesity
Not Provided
  • RYGBP
    Patients underwent Roux-en-Y Gastric Bypass for morbid obesity.
  • LAGB
    Patients underwent Laparoscopic Adjustable Gastric Banding for morbid obesity.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
Not Provided
February 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of morbid obesity
  • Being underwent LAGB or RYGBP

Exclusion Criteria:

  • Having prior abdominal surgery history
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
 
NCT01613391
IU-BS-2012-RAV
Not Provided
Not Provided
Not Provided
Muhammet Ferhat CELİK, Istanbul University
Istanbul University
Not Provided
Not Provided
Istanbul University
June 2012